Anika Cost Of Revenue from 2010 to 2024
| ANIK Stock | USD 25.97 0.40 1.56% |
Cost Of Revenue | First Reported 1993-03-31 | Previous Quarter 16.5 M | Current Value 16.6 M | Quarterly Volatility 4.7 M |
Check Anika Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anika main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.9 M, Interest Expense of 1.2 M or Selling General Administrative of 103.5 M, as well as many exotic indicators such as Price To Sales Ratio of 3.33, Dividend Yield of 310 or PTB Ratio of 1.73. Anika financial statements analysis is a perfect complement when working with Anika Therapeutics Valuation or Volatility modules.
Anika | Cost Of Revenue |
Latest Anika Therapeutics' Cost Of Revenue Growth Pattern
Below is the plot of the Cost Of Revenue of Anika Therapeutics over the last few years. Cost of Revenue is found on Anika Therapeutics income statement and represents the costs associated with goods and services Anika Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Anika Therapeutics' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anika Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Cost Of Revenue | 10 Years Trend |
|
Cost Of Revenue |
| Timeline |
Anika Cost Of Revenue Regression Statistics
| Arithmetic Mean | 36,873,852 | |
| Geometric Mean | 29,138,460 | |
| Coefficient Of Variation | 56.61 | |
| Mean Deviation | 17,986,592 | |
| Median | 28,747,000 | |
| Standard Deviation | 20,873,532 | |
| Sample Variance | 435.7T | |
| Range | 64.9M | |
| R-Value | 0.88 | |
| Mean Square Error | 102.4T | |
| R-Squared | 0.78 | |
| Significance | 0.000012 | |
| Slope | 4,126,974 | |
| Total Sum of Squares | 6099.9T |
Anika Cost Of Revenue History
About Anika Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Anika Therapeutics income statement, its balance sheet, and the statement of cash flows. Anika Therapeutics investors use historical funamental indicators, such as Anika Therapeutics's Cost Of Revenue, to determine how well the company is positioned to perform in the future. Although Anika Therapeutics investors may use each financial statement separately, they are all related. The changes in Anika Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Anika Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Anika Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Anika Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cost Of Revenue | 63.6 M | 66.8 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Anika Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Anika Therapeutics' short interest history, or implied volatility extrapolated from Anika Therapeutics options trading.
Pair Trading with Anika Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Anika Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anika Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Anika Stock
| 0.58 | ETON | Eton Pharmaceuticals Financial Report 9th of May 2024 | PairCorr |
| 0.56 | SBFMW | Sunshine Biopharma | PairCorr |
| 0.54 | EVOK | Evoke Pharma | PairCorr |
| 0.48 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Anika Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Anika Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Anika Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Anika Therapeutics to buy it.
The correlation of Anika Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Anika Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Anika Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Anika Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Anika Therapeutics Correlation against competitors. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Anika Stock analysis
When running Anika Therapeutics' price analysis, check to measure Anika Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anika Therapeutics is operating at the current time. Most of Anika Therapeutics' value examination focuses on studying past and present price action to predict the probability of Anika Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anika Therapeutics' price. Additionally, you may evaluate how the addition of Anika Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Anika Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Earnings Share (5.64) | Revenue Per Share 11.372 | Quarterly Revenue Growth 0.085 | Return On Assets (0.02) |
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.